ClinicalTrials.gg
CompletedNCT05946590Updated Sep 19, 2025

Breastfeeding Duration and Tongue-tie in Neonates.

An interventional study of Frenotomy in Infant Nutrition Disorders, sponsored by Hvidovre University Hospital. Completed at 1 site in Denmark. Open to participants aged Up to 49 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-19.

Sponsored by Hvidovre University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
Up to 49 Days
Sex
All
01

Study summary

The goal of this observational study is to examine how performed frenotomy in term-born infants influences the breastfeeding duration. The main questions the study aims to answer are how a suspected tongue-tie, vacuum strength, and breastfeeding may be associated. Families of infants with tongue-tie where frenotomy is suspected will be invited to participate. Intra-oral vacuum measurements before and 5-10 days after frenotomy will be obtained and the breastfeeding status followed for 6 months.

Read the detailed description

Exclusive breastfeeding is defined as feeding the infant with human breast milk only, except for vitamins, minerals supplements and medicine. It is an official recommendation that infants are exclusively breastfed for 6 months. Approximately 60% and 15% of Danish infants are exclusively breastfed for 4 and 6 months respectively. There are many factors that may interfere with the establishment and duration of breastfeeding.

For the infant, breastfeeding depends on the infant´s ability to seal the oral cavity around the breast and integrate the muscular activities of cheeks, lips, jaw, and tongue. Effectively nutritive sucking occurs due to the application of positive pressure when the tongue moves upwards to express milk, followed by an intra-oral vacuum (vacuum) when the tongue moves downwards and draws milk from the breast by suction. The strength of vacuum affects the effectiveness of milk removal from the breast and regulates the volume of milk. A weak vacuum may, therefore, lead to a shortage of milk transfer, diminished milk supply and early breastfeeding stop. Conversely, was in a recently published study found an association between a high vacuum and infants who were exclusively breastfed for the recommended 6 months.

Difficulties in creating an appropriate vacuum may be related to ankyloglossia, tight frenulum also called tongue-tie, a condition in which the lingual frenulum has anterior attachment near the tip of the tongue and/or are unusually thick, tight, and/or short lingual frenulum. Tongue-tie is often detected when the infant shows signs of difficulties during breastfeeding and/or there is maternal nipple pain. The possible consequence of tongue-tie is insufficient infant weight gain, neonatal dehydration, and shortened breastfeeding duration.

In case of breastfeeding difficulties, it is recommended to evaluate the tongue-tie by the Breastfed Babies Assessment Tool score (TABBY) and depending on this assessment frenotomy may be recommended. The value of both the TABBY score and frenotomy is only poorly validated.

Hypothesis We hypothesise vacuum to increase after frenotomy and, thereby, affect breastfeeding duration positively.

02

Conditions studied

  • Infant Nutrition Disorders

Keywords

  • Ankyloglossia
  • Frenotomy
  • Infants
  • Intra-oral vacuum
  • Breastfeeding
03

In context

Infant Nutrition Disorders

67 studies on the registry are indexed under Infant Nutrition Disorders; 14 are open to participants now.

This study's enrollment of 100 is below the median of 180 across 46 interventional studies indexed under Infant Nutrition Disorders.

Browse Infant Nutrition Disorders studies →

Lead sponsor

Hvidovre University Hospital is the lead sponsor of 299 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 49 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Infant of an adult mother Delivery after 37 completed gestational weeks. Singleton or twin Infant of a mother who intends to breastfeed. At least one parents speak and write English, Danish, Norwegian, or Swedish.

Exclusion criteria

Exclusion Criteria:

Congenital malformation. Reduced lung function.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Other
    Frenotomy

    Frenotomy performed by a health care professional

    Procedure: Frenotomy

Interventions

  • ProcedureFrenotomy

    Frenotomy in which clipping/incised of the lingual frenulum releases the tongue-tie performed by a health care professional

    Also known as: Frenulum release

06

What researchers measure

Primary outcomes

  1. Breastfeeding duration

    The duration of exclusive and partial breastfeeding

    Time frame: Followed 6 months.

Secondary outcomes

  1. TABBY score

    The association between tongue-tie, TABBY score, and vacuum strength.

    Time frame: Before and 5-10 days after performed frenotomy.

  2. Delta intra-oral vacuum

    The primary outcome is to investigate any difference in vacuum in infants below 42 days

    Time frame: Before, within 1 hour after and 5-10 days after performed frenotomy.

07

Study locations

1 site
  • Diana Skaaning
    Hvidovre, Copenhagen 2650, Denmark
08

References and documents

Individual participant data

Plan to share: No — All personal information about potential and enrolled participants will be collected, shared, and maintained under protected confidentiality before, during, and after the study period according to Capital Region at Knowledge Center for Data Reviews and the General Data Protection Regulation.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Nov 2024, 11 months.

Of 25 interventional studies with no phase under Infant Nutrition Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 27. This study's 11 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2023
First posted
Jul 14, 2023
StartActual
Nov 17, 2023
Primary completionActual
Nov 1, 2024
CompletionActual
Nov 1, 2024
Last update
Sep 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05946590
Responsible party
Diana Skaaning (Clinical Supervisor, Hvidovre University Hospital) — Principal investigator
First posted
Jul 14, 2023
Start date
Nov 17, 2023
Primary completion
Nov 1, 2024
Completion
Nov 1, 2024
Last update
Sep 19, 2025

Study contacts

Diana Skaaning
principal investigator · Region Hovedstadens Apotek

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion